Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock,$0.001 par value per share
- Shares outstanding
- 72,096,078
- Total 13F shares
- 67,021,594
- Share change
- +2,678,545
- Total reported value
- $1,152,767,927
- Put/Call ratio
- 192%
- Price per share
- $17.20
- Number of holders
- 108
- Value change
- +$44,945,526
- Number of buys
- 53
- Number of sells
- 44
Quarterly Holders Quick Answers
What is CUSIP 98943L107?
CUSIP 98943L107 identifies ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98943L107:
Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
|
Company |
13%
|
9,199,973
|
$185,287,456 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
11%
|
7,909,176
|
$159,290,805 | — | 31 Dec 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
7.1%
|
5,150,000
|
$103,721,000 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
4,160,149
|
$83,785,400 | — | 31 Dec 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5%
|
3,618,493
|
$72,876,448 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
3,472,179
|
$69,929,685 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
3,084,137
|
$62,114,519 | — | 31 Dec 2022 | |
| Capital International Investors |
13F
|
Company |
4.2%
|
3,048,182
|
$61,390,385 | — | 31 Dec 2022 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.1%
|
2,231,427
|
$44,940,940 | — | 31 Dec 2022 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.1%
|
2,210,442
|
$44,519,000 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3%
|
2,176,700
|
$43,839,000 | — | 31 Dec 2022 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
3%
|
2,156,515
|
$43,432,212 | — | 31 Dec 2022 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
2.5%
|
1,824,583
|
$36,747,102 | — | 31 Dec 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.9%
|
1,365,498
|
$27,501,130 | — | 31 Dec 2022 | |
| Anthony Y. Sun |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
2,592,141
|
$26,672,095 | — | 04 Apr 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.7%
|
1,211,600
|
$24,401,624 | — | 31 Dec 2022 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.6%
|
1,130,170
|
$22,761,624 | — | 31 Dec 2022 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.4%
|
1,004,045
|
$20,221,466 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
857,217
|
$17,264,000 | — | 31 Dec 2022 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1%
|
750,000
|
$15,105,000 | — | 31 Dec 2022 | |
| Iris Roth |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
350,000
mixed-class rows
|
$14,760,704 | — | 01 Mar 2023 | |
| Capital World Investors |
13F
|
Company |
0.95%
|
683,000
|
$13,755,620 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.88%
|
637,720
|
$12,843,681 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
420,044
|
$8,459,686 | — | 31 Dec 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.55%
|
394,534
|
$7,945,912 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
390,382
|
$7,862,294 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.47%
|
335,757
|
$6,762,146 | — | 31 Dec 2022 | |
| Mayo Clinic |
13F
|
Company |
0.41%
|
297,143
|
$5,984,460 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
240,340
|
$4,840,447 | — | 31 Dec 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.33%
|
240,008
|
$4,833,761 | — | 31 Dec 2022 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
234,607
|
$4,724,985 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
0.32%
|
231,988
|
$4,672,238 | — | 31 Dec 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.32%
|
229,348
|
$4,619,069 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.3%
|
218,964
|
$4,410,000 | — | 31 Dec 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.28%
|
201,000
|
$4,048,140 | — | 31 Dec 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.27%
|
194,933
|
$3,925,951 | — | 31 Dec 2022 | |
| Opaleye Management Inc. |
13F
|
Company |
0.23%
|
167,500
|
$3,373,450 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
158,185
|
$3,185,846 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
154,892
|
$3,119,525 | — | 31 Dec 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.2%
|
146,519
|
$2,950,893 | — | 31 Dec 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
146,029
|
$2,941,024 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
133,459
|
$2,687,863 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.18%
|
133,028
|
$2,677,000 | — | 31 Dec 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.18%
|
127,973
|
$2,577,255 | — | 31 Dec 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.18%
|
127,874
|
$2,575,383 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
116,070
|
$2,338,000 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
110,000
|
$2,215,400 | — | 31 Dec 2022 | |
| Alexis Pinto |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
60,729
mixed-class rows
|
$2,068,615 | — | 10 Feb 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.14%
|
101,934
|
$2,052,951 | — | 31 Dec 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.12%
|
85,645
|
$1,725,000 | — | 31 Dec 2022 |
Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q1 2023
As of 31 Mar 2023,
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,021,594 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, EVENTIDE ASSET MANAGEMENT, LLC, Capital International Investors, Avidity Partners Management LP, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
108
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
106
Q1 2023 holders
108
Holder diff
2
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.